tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sangamo sees cash runway into 1Q26
PremiumThe FlySangamo sees cash runway into 1Q26
2d ago
Sangamo sees FY25 operating expenses $135M-$155M
Premium
The Fly
Sangamo sees FY25 operating expenses $135M-$155M
2d ago
Sangamo Biosciences Granted Nasdaq Compliance Extension
Premium
Company Announcements
Sangamo Biosciences Granted Nasdaq Compliance Extension
10d ago
Sangamo presents detailed data from STAAR study
PremiumThe FlySangamo presents detailed data from STAAR study
2M ago
Sangamo Biosciences: Poised for Significant Value Creation with Promising Clinical Trials and Strategic Partnerships
Premium
Ratings
Sangamo Biosciences: Poised for Significant Value Creation with Promising Clinical Trials and Strategic Partnerships
3M ago
Sangamo Biosciences: Cautious Optimism in Earnings Call
Premium
Company Announcements
Sangamo Biosciences: Cautious Optimism in Earnings Call
3M ago
Unusually active option classes on open July 24th
PremiumThe FlyUnusually active option classes on open July 24th
4M ago
Cautious Optimism for Sangamo Biosciences Amid Promising Fabry Program Data and Ongoing Business Developments
Premium
Ratings
Cautious Optimism for Sangamo Biosciences Amid Promising Fabry Program Data and Ongoing Business Developments
4M ago
Sangamo Announces Positive Results for Fabry Disease Therapy
Premium
Company Announcements
Sangamo Announces Positive Results for Fabry Disease Therapy
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100